Novo Nordisk A/S (OTC Pink - Current Information:NONOF)

65.08
Delayed Data
As of Aug 14
 -0.86 / -1.30%
Today’s Change
48.41
Today|||52-Week Range
69.70
+12.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues16.0B16.6B16.9B17.7B
 
 
 
 
 
Cost of Goods Sold2.1B2.2B2.3B2.4B
 
 
 
 
 
Depreciation And Amortization389.4M393.9M435.2M602.9M
 
 
 
 
 
 
Operating ExpensesGross Income13.6B14.0B14.2B14.7B
 
 
 
 
 
General Expenses6.7B6.8B6.9B7.4B
 
 
 
 
 
Other Operating Expenses0.000.00-1.7M0.00
 
 
Research And Development1.9B2.0B2.0B2.1B
 
 
 
 
 
Total Operating Expenses9.2B9.4B9.6B10.4B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income6.9B7.2B7.3B7.3B
 
 
 
 
 
Extraordinary Credit0.000.0091.7M--
 
 
Extraordinary Charge-852.5M-116.3M-47.3M-252.0M
 
 
 
 
 
Interest Expense On Debt22.0M22.3M24.0M24.9M
 
 
 
 
 
Equity In Earnings2.1M3.6M2.1M1.9M
 
 
 
 
 
Other Expenses450.0M64.0M34.0M490.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income6.5B7.1B7.4B7.5B
 
 
 
 
 
Income Taxes-1.3B-1.5B-1.6B-1.4B
 
 
 
 
 
Net Income5.2B5.6B5.8B6.1B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.6B2.5B2.5B2.4B
 
 
 
 
 
Shares To Calculate EPS Diluted2.6B2.5B2.5B2.4B
 
 
 
 
 
 
Earnings Per ShareEPS$2.02$2.23$2.34$2.53
 
 
 
 
 
EPS Diluted$2.01$2.22$2.33$2.52